Holger Müller

Co-Managing Director of co.faktor

As co-Managing Director of co.faktor, which became a Cytel company in 2023, Holger is responsible for the company’s German ​market access, ​​medical communication, and patient relations.

Bringing more than 15 years of experience in the pharmaceutical industry and professional service organizations to the company, allows Holger and his team to support local and global clients in translating clinical evidence in communicable value to achieve access to innovative therapeutics. His expertise spans the entire pharmaceutical lifecycle, ranging from translational clinical studies to loss-of-exclusivity transitions across a number of ​​therapeutic areas.

Holger has a PhD in Chemistry from ETH Zürich and a Master’s degree in Chemistry from Leibniz Universität Hannover.